In this issue:
Short vs long course neoadjuvant radiotherapy
Aspirin improves survival for mutated PIK3CA
CRC Neoadjuvant therapy feasible for colon cancer
Adjuvant bevacizumab not recommended for colon cancer
Continue bevacizumab in second-line chemotherapy… ...or add
Please login below to download this issue (PDF)